Medication info
Topstatin F Tablets 10/5 milligrams

Topstatin F Tablets 10/5 milligrams

Prescription medicationTabletOral
Ingredient · strength
Ezetimibe›10mg / 1 tabletRosuvastatin Calcium›5.2mg / 1 tablet
Manufacturer / importer
Daehwa Pharmaceutical Co., Ltd.
Appearance
White to almost white round film-coated tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle, PTP - 30 tablets/box [10 tablets/PTP x 3]
Approval status
Active

MFDS item code 201601228 · Approved 2016.02.29 · Insurance code 645604720

Summary

Main use
Improvement of primary hypercholesterolemia and mixed dyslipidemia
Who takes it
Adults
Adult dose
This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.

Ingredients

Manufacturer
Daehwa Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of primary hypercholesterolemia and mixed dyslipidemia

  • Primary hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • non-familial hypercholesterolemia
  • mixed dyslipidemia
  • increased total cholesterol
  • increased LDL cholesterol
  • increased Apo B protein
  • increased triglycerides
  • increased non-HDL cholesterol
View approved original text

This medicine helps lower total cholesterol, LDL cholesterol, Apo B protein, triglycerides, and non-HDL cholesterol while increasing good HDL cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia. This treatment should be used in conjunction with an appropriate dietary regimen that includes saturated fat and cholesterol restrictions, and is administered as an adjunct when dietary management alone is insufficient. Additionally, this medication is used as a lipid-lowering therapy to reduce the risk of atherosclerotic vascular disease caused by hypercholesterolemia. It is important to identify other causes of dyslipidemia before treatment and to provide concomitant treatment as necessary. This medication contributes to improving cardiovascular health by regulating the patient’s blood lipid levels.

How to take

Adult dose

This medicine is administered once daily, with or without food. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient’s baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly. The dose may be increased to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same strengths of each active ingredient) for convenience.

Precautions

This medication has been reported to cause a rare side effect known as rhabdomyolysis, which can result in serious muscle damage. Particularly, for patients at risk of rapid deterioration of kidney function due to acute infections, hypotension, major surgeries or trauma, severe metabolic abnormalities, the use of this medication should be temporarily suspended or discontinued. Additionally, this medication should not be administered to patients with allergies to the active ingredient or components, patients with severe liver dysfunction, patients with muscle diseases, patients taking certain immunosuppressants, patients with severe kidney function impairment, pregnant women or women who may become pregnant, and nursing mothers. Patients who are prone to myopathy or rhabdomyolysis, such as those with moderate or severe renal impairment, hypothyroidism, a family history of muscle diseases, previous experiences of muscle toxicity from other statins or fibrates, patients with alcohol addiction, and Asian patients should use this medication with caution. This medication contains lactose and should not be given to patients with lactose intolerance or related genetic disorders. Regular liver function tests should be conducted while taking this medication, and treatment may be discontinued if liver enzyme levels become abnormally elevated. Additionally, if symptoms such as myalgia, muscle spasms, muscle weakness, fatigue, fever, etc. occur, the healthcare provider should be informed immediately, and blood tests should be performed to check for muscle damage if necessary. This medication may interact with other drugs; therefore, if the patient is taking other medications, they must inform their healthcare provider. Women who are pregnant or planning to become pregnant should not take this medication and must use appropriate contraceptive methods during treatment. The safety and efficacy in children and adolescents have not been sufficiently established, so its use is not recommended. Caution is needed when administering to the elderly as the risk of myopathy may increase. When storing this medication, it should be kept out of reach of children and should not be transferred to other containers.

Side effects

nasopharyngitis, arthralgia, headache, ALT elevation, AST elevation, myalgia, edema, elevated serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory tract infection, chest pain, facial edema, abnormal sensation, drug intolerance, colonic polyps, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, postural dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, onychomycosis, soft tissue infection, hepatic steatosis, liver impairment, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyl transferase, increased blood cholesterol, increased blood alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal rigidity, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory distress, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, thrombocytopenia, jaundice, hepatitis, transaminase elevation, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, muscle weakness, headache, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, rhabdomyolysis, weakness, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, cough, low back pain, abdominal distension, nausea, AST elevation, CK elevation, anaphylaxis, urticaria, erythema multiforme, elevated creatine phosphokinase, increased liver aminotransferase levels, thrombocytopenia, cholelithiasis, cholecystitis, diabetic neuropathy, tremor, epigastric pain, vomiting, gastritis, xerostomia, discomfort in the epigastric region, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, conjunctival injection, renal failure, liver dysfunction, increased serum creatinine, elevated blood pressure, increased blood urea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is recommended to keep it at room temperature between 1 degree and 30 degrees Celsius. Proper storage helps maintain the medication's effectiveness for a longer time.

Appearance and packaging

Appearance

White to almost white round film-coated tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle, PTP - 30 tablets/box [10 tablets/PTP x 3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.